Drug intelligence / Profile preview

Migu

Development stage: Preclinical
Lead developer: Shanghai University of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Migu is a traditional Chinese medicine (TCM) oral herbal preparation used primarily for the treatment of osteoporotic low back pain and to promote fracture healing. It is formulated as capsules or granules and contains water extracts from Bushenfang (BSF), a TCM formula. Clinical studies have shown that Migu capsules can alleviate bone pain and reduce functional disabilities in patients with osteoporotic low back pain. In animal models, it has been studied for its effects on osteoporotic fracture healing. The precise mechanism of action is not fully elucidated but is believed to involve modulation of bone metabolism and promotion of bone repair through multiple herbal components[3][4].

Brand names: Migu
Other names: Mi-GuMiGuMigu capsuleMigu capsules

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Migu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Migu.

Explore the full profile